AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,285,230 | +224.9% | 221,867 | +419.8% | 0.00% | – |
| Q2 2023 | $703,384 | -88.9% | 42,681 | -93.8% | 0.00% | -100.0% |
| Q1 2023 | $6,340,790 | +735.6% | 692,226 | +553.2% | 0.00% | – |
| Q4 2022 | $758,809 | +116.2% | 105,979 | +51.1% | 0.00% | – |
| Q3 2022 | $351,000 | +93.9% | 70,126 | -5.7% | 0.00% | – |
| Q2 2022 | $181,000 | -88.8% | 74,380 | -68.7% | 0.00% | – |
| Q1 2022 | $1,621,000 | +199.1% | 237,331 | +253.2% | 0.00% | – |
| Q4 2021 | $542,000 | +98.5% | 67,195 | +141.7% | 0.00% | – |
| Q3 2021 | $273,000 | -27.4% | 27,798 | -50.2% | 0.00% | – |
| Q2 2021 | $376,000 | +0.5% | 55,838 | +34.8% | 0.00% | – |
| Q1 2021 | $374,000 | +179.1% | 41,413 | +105.8% | 0.00% | – |
| Q4 2020 | $134,000 | +36.7% | 20,127 | +3.2% | 0.00% | – |
| Q3 2020 | $98,000 | -26.3% | 19,500 | +18.1% | 0.00% | – |
| Q2 2020 | $133,000 | +454.2% | 16,505 | +450.2% | 0.00% | – |
| Q1 2020 | $24,000 | +100.0% | 3,000 | -37.7% | 0.00% | – |
| Q4 2018 | $12,000 | -73.9% | 4,819 | -54.6% | 0.00% | – |
| Q3 2018 | $46,000 | +64.3% | 10,604 | +130.8% | 0.00% | – |
| Q2 2018 | $28,000 | +12.0% | 4,595 | +29.3% | 0.00% | – |
| Q1 2018 | $25,000 | -87.9% | 3,554 | -85.9% | 0.00% | – |
| Q4 2017 | $207,000 | -55.6% | 25,222 | -43.3% | 0.00% | – |
| Q3 2017 | $466,000 | +19.5% | 44,449 | +25.9% | 0.00% | – |
| Q2 2017 | $390,000 | +23.0% | 35,304 | +7.8% | 0.00% | – |
| Q1 2017 | $317,000 | – | 32,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |